
Purchaser Advantages: Jaryeefine Consulting is a consulting firm focused on the cross-border healthcare sector between China and the U.S., assisting Chinese pharmaceutical, diagnostic, medical device, and digital health companies in entering the U.S. market. Services include FDA registration and compliance consulting, regulatory support for both China and the U.S., localization assistance, market entry, and BD strategy development. The team consists of former FDA experts, offering bilingual and bicultural advantages, proprietary platform resources, and an equity cooperation mechanism.
| Published by | Jaryeefine Consulting | Department | -- |
|---|---|---|---|
| Region | Massachusetts,United States of America | Budget | -- |
| Validity | Expires in 34 days | ||
1. Requirements Description
Seeking medical and health companies or projects with intentions to expand overseas. Interested parties are welcome to communicate.
2. Company Profile
Jaryeefine Consulting is a professional consulting firm focused on the cross-border healthcare sector between China and the U.S., under the Jaryeefine Holding platform. We are dedicated to helping China's pharmaceuticals, diagnostics, medical devices, and digital health companies efficiently enter the U.S. market, covering registration strategy design, review document preparation, FDA communication support, and commercial integration.
Our Services:
1. FDA Registration and Digital Health Compliance Consulting: We cover all FDA review centers (CDRH, CBER, CDER, OPEQ) and provide registration pathway planning (e.g., 510(k) pre-market approval, De Novo, BLA, NDA, etc.), Q-sub/Pre-Sub preparation, technical document writing (CMC, UDI, algorithm validation, labeling, etc.), and full-process interaction support with the FDA for in vitro diagnostics, medical devices, pharmaceuticals, biologics, and AI/software products.
2. Sino-US Regulations and Localization Support: Assistance in establishing a U.S. company, tax planning, label conversion, cold chain logistics, sample pathways, etc.
3. Market Landing and BD Strategy: MVP Commercial Path Design, Exhibition, Channel, Financing, and License Support.
Our Advantages:
Former FDA Expert Team (13 members, with over 170 years of cumulative experience)
Bilingual and Bicultural + Full-process Adaptation for US-China Review
Own platform resources (registration, testing, logistics, etc.)
Equity Cooperation Mechanism (SAFE, SPV, License-Split)